Commercial Partners
Worldwide network
IAD has been approved and marketed in 43 countries worldwide including EU member states (Austria, Belgium, France, Germany, Greece, Ireland, Italy, Luxemburg, Portugal and United Kingdom), Canada, Japan and Middle East territories (Bahrain, Egypt, Kuwait and U.A.E). Newport holds worldwide registrations for the trade names Isoprinosine®, Imunovir®, Viruxan®, Virimun® and Delimmun® amd territories. IAD is marketed internationally through an expanding network of licensees and distributors.
| Country | Representative |
| Eastern Europe | Ewopharma AG |
| Egypt |
Medical Union Pharmaceutical Co. |
| Japan | Mochida Pharmaceutical Co. Ltd |
| Indonesia | PT Darya-Varia Laboratoria Tbk |
| France, Francophone Africa, Morocco, Belgium | Sanofi-Aventis |
| Italy | Sigma Tau S.p.A. |
| Greece | Uni-Pharma Kleon Tsetis S.A. |
| United Kingdom, Ireland, Germany, Turkey, Malta, United Areb Emirates, Canada, Kuwait, New Zealand |
Kora Healthcare |